BioGene Therapeutics Inc.
BioGene Therapeutics Inc.36
About
What does BioGene Therapeutics Inc. do?
BioGene Therapeutics Inc. is a Texas-based life sciences company dedicated to advancing innovative therapies for metabolic disorders and gene-based treatments. They are actively engaged in pioneering research, including GLP-1 receptor agonists and gene therapies, to combat the global diabetes and obesity crisis. Their lead program focuses on a sustained-release nasal spray to inhibit PTP1B, a key enzyme in metabolic dysfunction.
What is BioGene Therapeutics Inc.'s Effective Domain Rating?
StartupHub's Effective Domain Rating for BioGene Therapeutics Inc. is 0 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is fairly rated against its Ahrefs Domain Rating of 2.6.
Is BioGene Therapeutics Inc. trustworthy and reputable?
StartupHub's Data Trust & Reputation score for BioGene Therapeutics Inc. is 79 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
What is BioGene Therapeutics Inc.'s revenue?
StartupHub estimates BioGene Therapeutics Inc.'s annual revenue at $858K (range $493K to $1.3M, 62% confidence), based on comparable companies in the sector.
Where is BioGene Therapeutics Inc. headquartered?
BioGene Therapeutics Inc. is headquartered in Houston, United States.
What industry does BioGene Therapeutics Inc. operate in?
BioGene Therapeutics Inc. operates in Biotech, MedTech, HealthTech, Genomics, Drug Discovery, Gene Therapy.
How many employees does BioGene Therapeutics Inc. have?
BioGene Therapeutics Inc. has approximately 8 people on record.
No comments yet. Be the first to share your take.